Canada’s Drug Agency (CDA-AMC) received a request to analyze MRI exam trends over 16 years to inform policy decisions related to diagnostic imaging capacity and access. Because MRI scans play a key role in diagnostics, growing demand may impact imaging services, wait times, and access.
